Company
Ambros Therapeutics, Inc.
Ambros Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 3.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Neridronate | Phase 3 | Complex Regional Pain Syndrome Type I |
Latest
No recent events.
Follow Ambros Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.